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195 Pulmonary function in cystic ﬁbrosis children younger than
3 years old
S. Zaragoza1, S. Lubovich1, V. Rodriguez1, J. Balinotti1, C. Kofman1, A. Teper1.
1Ricardo Gutierrez Children’s Hospital, Buenos Aires, Argentina
Studies suggest that the decline in pulmonary function begins early in CF infants
even in those patients without respiratory symptoms.
Objective: to describe pulmonary function in CF children younger than 3 years
old and to determine if there is any association between pulmonary function and
clinical features.
Methods: observational and retrospective, study. We collected data from CF patients
who underwent an Infant Pulmonary Function Test (IPFT) before the age of three
years. IPFTs were assessed by partial ﬂow/volume curves with the rapid thoracic-
abdominal compression technique to obtain the maximal ﬂow at the functional
residual capacity (V′maxFRC). Clinical issues recorded were: age, gender, genetics,
pancreatic sufﬁciency, nutritional status and microbiological ﬁndings.
Results: 46 patients (31 males) with a median (interquartile range) age of 8 months
(5 to 15) were included. Overall V′maxFRC Z score was −0.8 (−1.4 to 0.3), −0.1
(−1.1 to 0.7) in males and −0.9 (−1.8 to 0.3) in females (p =NS). V′maxFRC
Z score was −0.3 (−1.1 to 0.2) in children younger than 6 months and −0.1 (−1.3
to 1) in older ones (p =NS). In patients homozygous p.508del V′maxFRC Z score
was −0.5 (−1.2 to 0.8) while in patients with other mutations it was −0.2 (−1.2
to 0.6) (p =NS). There was also no statistical difference in V′maxFRC between
well-nourished and bad-nourished patients, and between patients with and without
Pseudomonas aeruginosa (PA) in sputum.
Conclusion: IPFT assessed by partial ﬂow/volume curves was normal in our CF
population less than 3 years old. We have not found any difference in pulmonary
function comparing CF children with different clinical features.
196 FEV1 decline in cystic ﬁbrosis (CF): much attention should be
devoted to children and adolescents
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The rate of decline in FEV1 percentage predicted has been studied in CF to identify
the risk of death, risk factors for decline and effect of therapeutic interventions. The
aims of our study were to assess the FEV1 decline in CF patients and to compare
it in male and female population.
atients aged 6 to 11 (A), 12 to 17 (B), 18 to 23 (C), 24 to 29 (D), 30 to 35 (E)
and >36 years (F), attending at our CF Centre were included. All spirometries,
performed over a 4 year period (2006–2009), were considered for each patient.
Individual decline in FEV1 predicted was evaluated using linear regression anal-
ysis. 176 (94 males) patients were included. Median (IQR) value of number of
spirometries was 15 (9, 22). Median values of baseline FEV1 and decline in FEV1
were: 105 (89, 117) and −2.02 (−8.55, 2.23) in A, 84 (74, 94) and −1.85 (−4.20,
2.16) in B, 70 (50, 84) and −0.77 (−2.04, 1.02) in C, 66 (38, 93) and −1.18 (−1.71,
0.92) in D, 49 (39, 66) and −1.12 (−2.66, −0.14) in E, 48 (35, 75) % predicted and
0.24 (−1.56, 1.78) % pred/yr in F, respectively. We found no signiﬁcant differences
in FEV1 decline between males and females in all age groups. In conclusion, we
observed an higher decline in lung function during the pediatric age compared to
adult age.
This ﬁnding suggests to adapt therapeutic interventions in children and adolescents
with the aim to slow the loss of lung function. Gender is not a risk factor in our
population. Other risk factors should be assessed to identify which subjects need
aggressive therapy.
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Aims: To identify the age at which young children with CF ﬁrst acquire P. aerug-
inosa (PA). To elucidate oropharyngeal PA in healthy infants same aged.
Methods: Observational, prospective study. CF cohort patients: infant with cystic
ﬁbrosis disease diagnosed by neonatal screening, from October 1999 to February
2005 and follow-up from diagnose to four years of life. Healthy infants: up to
4 year old children, without lung pathology who needs scheduled surgery. Data
from CF patients was a longitudinal study, but Healthy infants data was a cross-
sectional information, because ethical aspects. Specimens were taken applying the
oropharyngeal suction (OPS) technique. CF cohort patients: 877 specimens were
obtained from 18 patients; were taken monthly and should they develop lung
infection. Healthy infants: 104 specimens were taken, from 104 infants, during
anaesthesia induction. A signed consent was obtained previously.
Conclusions: PA was isolated at 15/18 of CF patients before 4 years of life, and
44.4% before12 months old. The 1st PA isolated was at 2−31 months (median 11).
We detected PA in 3/104 specimens from healthy patients, at 7, 18 and 38 months
old. We isolated PA at both groups (CF patients 3.76% vs Healthy infants 2.88%)
and no statistically signiﬁcant differences were found.
The presence of PA in upper airway culture from CF patients is early. The isolation
of PA in an upper airway culture should not be patognomonic for cystic ﬁbrosis.
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Aim: The aim of the study was to compare the results of PFTs in CF pts colonized with SA and PA.
Material and Methods: The group under study comprised the selected group of CF pts able to
undergo PFT. The study was carried out from 2008–2010. The pts had 3−4 appointments a year. Two
standard tests, PFT and bacteriological test were performed at each appointment. The Master Lab −
Jaeger’s was used to carry out PFTs. The specimens for bacteriology evaluation were sputum samples
and oropharingeal swabs. Identiﬁcation testing was performed by use of standard methods.
The group under study consisted of 34 pts. The group colonized with SA comprised 22 pts, 12 girls
and 10 boys aged 7−18. Out of total SA strains (n = 57) there were 5 MRSA isolated. The group
colonized with PA comprized 12 pts (6 pts PA chronic infection, 6 pts PA intermittent infection),
7 girls, 5 boys aged 7−18. In 58 cultured samples there were 31 MSSA, 1 MRSA, 48 PA isolated
(out of them 21 PA mucoid phenotypes).
Results: See the tables.
The characteristics of CF pts.
CF patients age [years]
mean±SD
height [cm]
mean±SD
weight [kg]
mean±SD
BMI [kg/m2]
mean±SD
S.a. pts n = 22 12.74±2.76 151.45±14.95 40.18±13.17 16.93±2.64
P.a. pts n = 12 12.61±2.42 151.61±11.16 38.23±10.28 16.30±2.43
p* 0.3952 0.4724 0.1865 0.0947
PFT in CF patients
CF patients VC %pred
mean±SD
FEV1 % pred
mean±SD
FEV1%VC
mean±SD
FEF50 %pred
mean±SD
Raw %pred
mean±SD
TLC %pred
mean±SD
S.a. pts n = 22 89.15±20.90 80.06±23.54 73.91±12.89 63.70±28.27 203.90±96.10 102.83±16.71
P.a. pts n = 12 83.80±21.06 73.11±28.51 69.78±15.08 56.29±35.29 233.07±169.81 99.68±7.73
p* 0.0922 0.0883 0.0669 0.1198 0.1503 0.0895
* T-Student’s test
Conclusions: In the chronically colonized CF pts under study SA colonized pts comprise larger
group, approximately 65%. The mean age, height, weight and BMI are very similar in both groups.
PFT results in SA pts are slightly better, but the difference is not statistically signiﬁcant.
